Medical News

RSS

USMD Holdings' primary care clinics receive reaccreditation from PCMH Program

USMD Holdings, Inc., a physician-led integrated healthcare system, announced today that all 26 of its primary care clinics have received reaccreditation for an additional three-year term from the Patient-Centered Medical Home (PCMH) Program, a recognition program that is part of the National Committee for Quality Assurance.

11 Mar 2014

Apollo Medical Holdings launches ApolloMed Care Clinics

Apollo Medical Holdings, Inc., an integrated physician-centric healthcare delivery company, today announced the launch of ApolloMed Care Clinics, which will serve as both primary care medicine and post-discharge centers of excellence. As part of this strategy, ApolloMed has acquired three primary care clinics and started a de novo clinic.

11 Mar 2014

As enrollment deadline looms, subsidies still confuse some consumers

The Wall Street Journal unveils a calculator to help explain these tax credits, or subsidies, while the CT Mirror looks at last-minute consumer questions.

11 Mar 2014

Innovative study uses pharmacogenomic test to treat patients with psychotic disorders

ValueOptions, Inc. a health improvement company specializing in mental and emotional well-being and recovery, and Genomind, a personalized medicine company, today announced an innovative study that uses pharmacogenomic testing to treat patients diagnosed with psychotic disorders, including schizophrenia and bipolar disorder.

11 Mar 2014

Health2 Resources becomes Executive Member of Patient-Centered Primary Care Collaborative

Health2 Resources announced today it has joined the Patient-Centered Primary Care Collaborative as an Executive Member. Executive Members guide the PCPCC's efforts to advance an effective health system built on a strong foundation of primary care and the patient-centered medical home (PCMH).

11 Mar 2014

APAPO recognizes Senator Sherrod Brown with 2014 Outstanding Leadership Award

Senator Sherrod Brown (D-OH) was honored last night by the American Psychological Association Practice Organization for his advocacy work and legislative accomplishments on mental health issues. APAPO recognized Sen. Brown with the 2014 Outstanding Leadership Award, given annually to a member of Congress who has done good work on behalf of professional psychology.

11 Mar 2014

Administration reverses course on proposed Medicare drug changes

After advancing a number of changes to the Medicare Part D program earlier this year, the Centers for Medicare & Medicaid Services withdrew its plan, which had drawn significant opposition from patients, drug companies and lawmakers in both parties.

11 Mar 2014

Aetna, Atlantic ACO announce new accountable care agreement

Aetna and Atlantic Accountable Care Organization, a partner of Atlantic Health System, today announced a new accountable care agreement that will improve the coordination and delivery of patient care. Atlantic ACO will deliver a better patient experience for more than 28,000 Aetna members in Morris, Sussex, Union, Somerset, Warren and Passaic counties.

11 Mar 2014

Rexahn reports initial results from Supinoxin Phase I trial in patients with solid cancer tumors

Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company announced today initial data for the Phase I dose-escalation clinical trial of SupinoxinTM (RX-5902) initiated in August 2013. This trial was designed to study safety and efficacy in patients with solid cancer tumors.

11 Mar 2014

IPC The Hospitalist Company announces recipients for 2013 Hospitalist of the Year award

IPC The Hospitalist Company, Inc., a leading national physician group practice company, today announced the recipients for its 2013 Hospitalist of the Year award. The IPC awards program, now in its sixth year, recognizes IPC clinical leaders who have made outstanding contributions to the Company, to their facility and to the patients they serve, both in acute care and post-acute care settings.

11 Mar 2014

Synta Pharmaceuticals' Hsp90 inhibitor ganetespib selected for study in I-SPY 2 TRIAL

Synta Pharmaceuticals Corp. and QuantumLeap Healthcare Collaborative today announced that Synta's lead drug candidate, the Hsp90 inhibitor ganetespib, has been selected for study in the I-SPY 2 TRIAL (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging And moLecular Analysis 2).

11 Mar 2014

Clinipace Worldwide closes merger with Choice Pharma

Clinipace Worldwide, a global digital contract research organization (dCRO), announced today the closing of its merger with Choice Pharma, a Pan-Asian contract research organization. Bringing these organizations together strengthens Clinipace Worldwide's operational and therapeutic expertise in Asia, a region in high demand by Clinipace's clients.

11 Mar 2014

New version of QuadraMed Computerized Patient Record now available

QuadraMed Corporation is pleased to announce the General Availability of the next major version of its enterprise EHR solution, QuadraMed Computerized Patient Record. QCPR version 6.0 provides key capabilities and improvements that help organizations provide high-quality and efficient care; meet pressing Canadian, as well as U.S. governmental and industry regulations; and deliver better patient safety, patient engagement, data security, and privacy while being fully interoperable.

11 Mar 2014

Hi-Tech Pharmacal's third fiscal quarter net sales decrease 7% to $59.9 million

Hi-Tech Pharmacal Co., Inc. today reported results for the third fiscal quarter ended January 31, 2014.

11 Mar 2014

NextImage completes acquisition of WorkWell

NextImage Medical, a leading provider of specialized cost containment services to the workers' compensation industry, today announced that it has completed the purchase of WorkWell, Inc. The individual company product lines will continue to operate under their respective names. Liz Griggs, Chairman and CEO of NextImage Medical, will become the CEO of the combined entity. The financial terms of the acquisition were not made public.

11 Mar 2014

NeuroDerm enrolls patients in second ND0612 Phase II clinical trial for treatment of Parkinson's disease

NeuroDerm, Ltd. announced today that enrollment of patients is ongoing in its second Phase II clinical trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease. ND0612 is a proprietary levodopa/carbidopa liquid formulation under development for continuous subcutaneous administration through a patch pump. It is designed to provide steady levodopa blood levels for the treatment of Parkinson's disease.

11 Mar 2014

Exosome Diagnostics closes Series B financing round with the raising of $27 million

Exosome Diagnostics today announced the initial close of its Series B financing round with the raising of $27 million. Proceeds will be used to advance development of the Company's proprietary platform technology and commercial programs for non-invasive, fluid-based molecular diagnostics in oncology, neurodegenerative diseases and other clinical areas.

11 Mar 2014

Almost Family reports record net service revenues of $96.3 million in Q4 2013

Almost Family, Inc., a leading regional provider of home health nursing and personal care services, announced today its financial results for the three months and full year ended December 31, 2013.

11 Mar 2014

Study examines long-term outcomes of patients treated in inpatient rehabilitation hospitals

A new study released today at a meeting of the American Medical Rehabilitation Providers Association (AMRPA) shows that patients treated in inpatient rehabilitation hospitals and units had better long-term clinical outcomes than those treated in nursing homes.

11 Mar 2014

Kindred Healthcare intends to undertake refinancing of existing secured indebtedness

Kindred Healthcare, Inc. today announced that it intends to undertake a refinancing of its existing secured indebtedness. The proposed refinancing would extend the maturity profile of the Company's long-term debt, increase total availability under the Company's secured facilities, improve pricing and provide additional covenant flexibility.

11 Mar 2014

Medical News

USMD Holdings' primary care clinics receive reaccreditation from PCMH Program

Apollo Medical Holdings launches ApolloMed Care Clinics

As enrollment deadline looms, subsidies still confuse some consumers

Innovative study uses pharmacogenomic test to treat patients with psychotic disorders

Health2 Resources becomes Executive Member of Patient-Centered Primary Care Collaborative

APAPO recognizes Senator Sherrod Brown with 2014 Outstanding Leadership Award

Administration reverses course on proposed Medicare drug changes

Aetna, Atlantic ACO announce new accountable care agreement

Rexahn reports initial results from Supinoxin Phase I trial in patients with solid cancer tumors

IPC The Hospitalist Company announces recipients for 2013 Hospitalist of the Year award

Synta Pharmaceuticals' Hsp90 inhibitor ganetespib selected for study in I-SPY 2 TRIAL

Clinipace Worldwide closes merger with Choice Pharma

New version of QuadraMed Computerized Patient Record now available

Hi-Tech Pharmacal's third fiscal quarter net sales decrease 7% to $59.9 million

NextImage completes acquisition of WorkWell

NeuroDerm enrolls patients in second ND0612 Phase II clinical trial for treatment of Parkinson's disease

Exosome Diagnostics closes Series B financing round with the raising of $27 million

Almost Family reports record net service revenues of $96.3 million in Q4 2013

Study examines long-term outcomes of patients treated in inpatient rehabilitation hospitals

Kindred Healthcare intends to undertake refinancing of existing secured indebtedness

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Latest News